| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $14.3B | $14.7B | $15.4B | $16.3B | $17.9B | $11.9B | $0.0B |
| Cost of Revenue | $9.3B | $9.1B | $9.0B | $9.8B | $12.3B | $8.1B | — |
| Gross Profit | $5.0B | $5.6B | $6.4B | $6.5B | $5.6B | $3.8B | — |
| R&D Expense | — | — | — | — | $0.8B | $0.6B | — |
| SG&A Expense | $3.8B | $4.4B | $4.7B | $4.2B | $4.5B | $3.3B | — |
| Operating Income | $-2.7B | $0.0B | $0.8B | $1.6B | $-0.0B | $-0.2B | — |
| Net Income | $-3.5B | $-0.6B | $0.1B | $2.1B | $-1.3B | $-0.7B | $0.0B |
| EPS (Basic) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | $0.00 |
| EPS (Diluted) | $-3.00 | $-0.53 | $0.05 | $1.71 | $-1.05 | $-1.11 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $37.2B | $41.5B | $47.7B | $50.0B | $54.8B | $61.6B | $0.0B |
| Current Assets | $9.8B | $9.5B | $13.0B | $10.6B | $10.9B | $12.9B | $0.0B |
| Cash & Equivalents | $1.3B | $0.7B | $1.0B | $1.3B | $0.7B | $0.8B | — |
| Total Liabilities | $22.5B | $22.9B | $27.2B | $28.9B | $34.4B | $38.6B | $0.0B |
| Current Liabilities | $7.1B | $5.8B | $7.8B | $6.7B | $9.9B | $10.6B | $0.0B |
| Stockholders' Equity | — | — | — | — | — | — | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.3B | $2.3B | $2.8B | $3.0B | $3.0B | $1.2B | $0.0B |
| Investing Cash Flow | $-0.4B | $1.8B | $-0.8B | $1.5B | $-0.1B | $-0.3B | $0.0B |
| Capital Expenditures | $0.4B | $0.3B | $0.4B | $0.4B | $0.5B | $0.2B | — |
| Financing Cash Flow | $-1.3B | $-4.3B | $-2.3B | $-3.9B | $-3.0B | $-0.6B | $0.0B |